Log in to save to my catalogue

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Identification of early neurodegenerative pathways in progressive multiple sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_kth_324939

Identification of early neurodegenerative pathways in progressive multiple sclerosis

About this item

Full title

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Publisher

New York: Nature Publishing Group US

Journal title

Nature neuroscience, 2022-07, Vol.25 (7), p.944-955

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Progressive multiple sclerosis (MS) is characterized by unrelenting neurodegeneration, which causes cumulative disability and is refractory to current treatments. Drug development to prevent disease progression is an urgent clinical need yet is constrained by an incomplete understanding of its complex pathogenesis. Using spatial transcriptomics and...

Alternative Titles

Full title

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_kth_324939

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_kth_324939

Other Identifiers

ISSN

1097-6256,1546-1726

E-ISSN

1546-1726

DOI

10.1038/s41593-022-01097-3

How to access this item